Healthcare Triangle, Inc. (HCTI)

NASDAQ: HCTI · USD

$6.80

+0.00 (0.0%)· Recorded snapshot

Market cap	5.1M
Revenue (ttm)	25.7M
Net income (ttm)	-17M
EPS (ttm)	-$430
Shares out	748.7K
Volume	17,671
Beta	1.09

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 25.7M
Net income (ttm): -17M
EPS (ttm): -$430
Market cap: 5.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-57.4

P25 -113.8P50 -46.5P75 -0.9

ROIC-24.7

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All HCTI indicators

Market & fundamental data

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001839285
Company name	Healthcare Triangle, Inc.
Country	United States
Country code	US
CUSIP number	42227W405
Earnings date	2026-11-12
Earnings time	bmo
Employees	40
Employees change	-4
Employees growth	-9.09%
Enterprise value	$16.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2020
Industry	Health Information Services
IPO date	2021-10-13
Is primary listing	Yes
Is SPAC	No
ISIN number	US42227W4050
Last 10-K release date	2026-04-15
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2026-10-26
Last stock split type	Reverse
Market cap	$5.1M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$6.80
Price currency	USD
Sector	Healthcare
SIC code	7373
Stock price date	2026-10-28
Symbol	HCTI
U.S. state	California
Website	https://www.healthcaretriangle.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-6,317.05%
EV/Sales	0.63x
FCF / EV yield	-96.31%
FCF yield	-304.07%
Forward EV/Sales	0.81x
Forward P/S	0.26x
Industry forward P/E	34.62x
P/B ratio	0.03x
P/S ratio	0.2x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-57.37%
EBITDA margin	-51%
Gross margin	21.52%
Operating margin	-57.37%
Pretax margin	-66.21%
Profit margin	-66.3%
Profit per employee	$-425,575
Revenue per employee	$641,850
ROA	-20.87%
ROA (5Y)	-42.46%
ROCE	-25.55%
ROE	-57.41%
ROIC	-24.68%
SBC / revenue	1.27%
Tax / revenue	0.09%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	12
EPS growth years	3
Gross profit growth	206.83%
Gross profit growth (Q)	318.42%
Gross profit growth 3Y	-14.31%
Gross profit growth 5Y	-11.07%
Net income growth years	1
Revenue growth	116.37%
Revenue growth (Q)	158.38%
Revenue growth (QoQ)	-6.72%
Revenue growth 3Y	-14.86%
Revenue growth 5Y	-5.66%
Revenue growth quarters	5
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$547,000
Depreciation and amortization	$1.6M
EBIT	$-14.7M
EBITDA	$-13.1M
EPS	$-429.56
FCF per share	$-20.68
Financing cash flow	$25.1M
Free cash flow	$-15.5M
Free cash flow minus SBC	$-15.8M
Gross profit	$5.5M
Income taxes	$24,000
Investing cash flow	$-10.4M
Net borrowing	$13M
Net cash flow	$-1.3M
Net income	$-17M
Operating cash flow minus SBC	$-16.4M
Operating income	$-14.7M
Revenue	$25.7M
Stock-based compensation	$327,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-1.21
Book value per share	$234.28
Debt / equity	0.26
Goodwill	$2.9M
Interest coverage	-48.29
Long-term assets	$64M
Long-term liabilities	$8.6M
Net cash (debt)	$-11M
Net cash / market cap	-215.72%
Net debt / equity	0.22
Piotroski F-Score	2
Property, plant and equipment	$2.4M
Shareholders' equity	$49.1M
Tangible book value	$-34M
Tangible book value per share	$-335.53
Total assets	$73.6M
Total cash	$2M
Total debt	$13M
Total liabilities	$24.5M
WACC	4.22%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.58
Current assets	$9.6M
Current liabilities	$16M
Current ratio	0.6
Net working capital	$1.2M
Quick ratio	0.57
Working capital	$-6.3M
Working capital turnover	-80.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-7,691.61%
Dividend yield	0%
Shareholder yield	-7,691.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$31.93
1D price change	0%
1M price change	-58.42%
1M total return	-58.42%
1W price change	-17.89%
1W total return	-17.89%
1Y price change	-99.79%
1Y return CAGR	-99.8%
1Y total return	-99.79%
20-day SMA	$9.08
200-day SMA	$73.71
3M price change	-80.97%
3M total return	-80.97%
3Y price change	-100%
3Y return CAGR	-98.24%
3Y total return	-100%
50-day SMA	$13.22
50-day SMA vs 200-day SMA	50under200
52-week high	$3,767.99
52-week high date	2025-10-29
52-week low	$6.15
52-week low date	2026-10-26
5Y price change	-100%
5Y return CAGR	-93.95%
5Y total return	-100%
6M price change	-85.49%
6M total return	-85.49%
All-time high	$12,996,713.48
All-time high date	2021-10-13
All-time low	$6.15
All-time low date	2026-10-26
Average true range (ATR)	$1.75
Average volume	20.8K
Beta (1Y)	2.2
Beta (2Y)	0.76
Beta (5Y)	1.09
Change from 52-week high	-99.82%
Change from 52-week low	10.57%
Change from all-time high	-100%
Change from all-time low	5.2%
Change from open	0%
Day's gap	0%
Dollar volume	$120,163
High price	$6.80
Low price	$6.80
Monthly RSI	25.2
Open price	$6.80
Premarket change	3.17%
Premarket close	$6.80
Premarket price	$7.02
Premarket volume	289
Previous close	$6.80
Price vs 150-day SMA	-79.74%
Price vs 20-day SMA	-28.76%
Price vs 200-day SMA	-91.22%
Price vs 50-day SMA	-51.07%
Relative volume	0.85
Return from IPO open	-100%
Return from IPO price	70%
RSI	28.95
Sharpe ratio	-4.33
Sharpe ratio (3Y)	-0.68
Sharpe ratio (5Y)	-0.44
Sortino ratio	-5.01
Sortino ratio (3Y)	-1.23
Sortino ratio (5Y)	-0.8
Volume	17.7K
Weekly RSI	32.95
YTD price change	-99.15%
YTD total return	-99.15%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	748.7K
Float percentage	100%
Shares change (QoQ)	201.45%
Shares change (YoY)	7,691.61%
Shares held by insiders	0%
Shares held by institutions	0.31%
Shares outstanding	748.7K
Short ratio	0.2 days

Deeper analysis on HCTI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this HCTI report

Is a complete HCTI research report available?

No complete published report is available for Healthcare Triangle, Inc. (HCTI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Healthcare Triangle, Inc. (HCTI)

Price

Financial snapshot

Fair-value bridge

Latest news · HCTI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HCTI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on HCTI

Frequently asked questions